Document Detail


Investigation on chemotactic drug targeting (chemotaxis and adhesion) inducer effect of GnRH-III derivatives in Tetrahymena and human leukemia cell line.
MedLine Citation:
PMID:  23208929     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
GnRH-III has been shown to exert a cytotoxic effect on the GnRH-R positive tumor cells. The chemotactic drug targeting (CDT) represents a new way for drug delivery approach based on selective chemoattractant guided targeting. The major goal of the present work was to develop and investigate various GnRH-III derivatives as potential targeting moieties for CDT. The cell physiological effects (chemotaxis, adhesion, and signaling) induced by three native GnRHs (hGnRH-I, cGnRH-II, and lGnRH-III) and nine GnRH-III derivatives were evaluated in two model cells (Tetrahymena pyriformis and Mono Mac 6 human monocytes). According to our results, the native GnRH-III elicited the highest chemoattractant and adhesion inducer activities of all synthesized peptides in micromolar concentrations in monocytes. With respect to chemoattraction, dimeric derivatives linked by a disulfide bridge ([GnRH-III(C)](2) ) proved to be efficient in both model cells; furthermore, acetylation of the linker region ([GnRH-III(Ac-C)](2) ) could slightly improve the chemotactic and adhesion effects in monocytes. The length of the peptide and the type of N-terminal amino acid could also determine the chemotactic and adhesion modulation potency of each fragment. The application of the chemoattractant GnRH-III derivatives was accompanied by a significant activation of phosphatidylinositol 3-kinase in both model cells. In summary, our work on low-level differentiated model cells of tumors has proved that GnRH-III and some of its synthetic derivatives are promising candidates to be applied in CDT: these compounds might act both as carrier, delivery unit, and antitumor agents. Copyright © 2012 European Peptide Society and John Wiley & Sons, Ltd.
Authors:
Eszter Lajkó; Ildikó Szabó; Katalin Andódy; András Pungor; Gábor Mező; László Kőhidai
Related Documents :
24361339 - In vitro models of the metastatic cascade: from local invasion to extravasation.
23637989 - Circulating brain microvascular endothelial cells (cbmecs) as potential biomarkers of t...
23686079 - Fasting glucose level modulates cell surface expression of cd11b and cd66b in granulocy...
23559519 - Physicochemical regulation of endothelial sprouting in a 3d microfluidic angiogenesis m...
24909139 - Egfl7 is expressed in bone microenvironment and promotes angiogenesis via erk, stat3, a...
12145479 - Detection of a thrombolysis-related reduction in red blood cell adhesiveness/aggregatio...
24037969 - Enhancement of endothelialisation of coronary stents by laser surface engineering.
8738799 - Expression of vascular permeability factor (vpf/vegf) is altered in many glomerular dis...
21284079 - Electrospinning and biocompatibility evaluation of biodegradable polyurethanes based on...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-4
Journal Detail:
Title:  Journal of peptide science : an official publication of the European Peptide Society     Volume:  -     ISSN:  1099-1387     ISO Abbreviation:  J. Pept. Sci.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9506309     Medline TA:  J Pept Sci     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 European Peptide Society and John Wiley & Sons, Ltd.
Affiliation:
Department of Genetics Cell and Immunobiology, Semmelweis University, Nagyvárad tér. 4, H-1089, Budapest, Hungary.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  LRIG1 regulates cadherin-dependent contact inhibition directing epithelial homeostasis and pre-invas...
Next Document:  Novel wound dressing based on nanofibrous PHBV-keratin mats.